Publications en collaboration avec des chercheurs de Universidad de Cantabria (3)

2020

  1. Reducing residual thrombotic risk in patients with peripheral artery disease: Impact of the COMPASS trial

    Drugs in Context, Vol. 9

  2. Residual risk reduction opportunities in patients with chronic coronary syndrome. Role of dual pathway inhibition

    Expert Review of Clinical Pharmacology, Vol. 13, Núm. 7, pp. 695-706

2019

  1. Role of rivaroxaban in the prevention of atherosclerotic events

    Expert Review of Clinical Pharmacology, Vol. 12, Núm. 8, pp. 771-780